(Q43290402)

English

Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide

scientific article published on 18 August 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

11

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

2

object named as

Michael Weller

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

10

object named as

Oystein Fluge

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

author name string

Gregor Dresemann

1

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Mark A Rosenthal

3

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Ulrich Wedding

4

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Wolfgang Wagner

5

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Erik Engel

6

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Bernhard Heinrich

7

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Regine Mayer-Steinacker

8

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Anders Karup-Hansen

9

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Maximilian Mehdorn

12

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Eberhard Schleyer

13

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Dietmar Krex

14

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Ian N Olver

15

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Joachim P Steinbach

16

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Christian Hosius

17

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Christian Sieder

18

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Greg Sorenson

19

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Richard Parker

20

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Zariana Nikolova

21

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

publication date

18 August 2009

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

96

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

393-402

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

https://scigraph.springernature.com/pub.10.1007/s11060-009-9976-3

0 references

Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea

1 reference

https://pubmed.ncbi.nlm.nih.gov/19688297

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of imatinib in patients with recurrent gliomas of various histologies: a European Organisation for Research and Treatment of Cancer Brain Tumor Group Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19688297

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The hydroxyurea-induced loss of double-minute chromosomes containing amplified epidermal growth factor receptor genes reduces the tumorigenicity and growth of human glioblastoma multiforme

1 reference

https://pubmed.ncbi.nlm.nih.gov/19688297

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19688297

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Malignant gliomas in adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/19688297

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme

1 reference

https://pubmed.ncbi.nlm.nih.gov/19688297

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19688297

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bevacizumab: a treatment option for recurrent glioblastoma multiforme

1 reference

https://pubmed.ncbi.nlm.nih.gov/19688297

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of enzyme-inducing antiepileptic drugs on trough level of imatinib in glioblastoma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19688297

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecularly targeted therapy for malignant glioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19688297

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiforme

1 reference

https://pubmed.ncbi.nlm.nih.gov/19688297

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imatinib and hydroxyurea in pretreated progressive glioblastoma multiforme: a patient series

1 reference

https://pubmed.ncbi.nlm.nih.gov/19688297

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19688297

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11060-009-9976-3

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43290402&oldid=1985709743"